Improving cervical cancer screening access in Senegal
Adaptation and implementation of a patient navigation program for cervical cancer screening across contexts in Senegal
['FUNDING_R01'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-11058487
This study is working to make it easier for women in Senegal, especially in rural areas, to get screened for cervical cancer by providing support and guidance, so they can get the care they need if they test positive.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-11058487 on ClinicalTrials.gov |
What this research studies
This research aims to enhance cervical cancer screening in Senegal by implementing a patient navigation program tailored to local contexts. It addresses the significant barriers that women face in accessing screening services, particularly in rural areas where screening rates are alarmingly low. The program will focus on facilitating timely diagnosis and follow-up care for women who test positive for cervical cancer, thereby improving overall cancer outcomes. By learning from successful strategies used in higher-resource countries, the project seeks to adapt these methods to fit the unique challenges of Senegal's healthcare system.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 40 to 49 living in rural areas of Senegal who are at risk for cervical cancer.
Not a fit: Patients who do not reside in Senegal or are outside the targeted age group may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates and reduce mortality among women in Senegal.
How similar studies have performed: Previous studies in high-income countries have shown that patient navigation can effectively improve cancer screening and follow-up rates, suggesting potential success for similar approaches in Senegal.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DYKENS, JON ANDREW — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: DYKENS, JON ANDREW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.